Prognostic factors for outcome in patients with refractory and relapsed acute lymphocytic leukemia treated with inotuzumab ozogamicin, a CD22 monoclonal antibody.

Prognostic factors for outcome in patients with refractory and relapsed acute lymphocytic leukemia treated with inotuzumab ozogamicin, a CD22 monoclonal antibody.

Item
http://www.wikidata.org/entity/Q33893777
The clinical potential of inotuzumab ozogamicin in relapsed and refractory acute lymphocytic leukemiaRecent advances and novel treatment paradigms in acute lymphocytic leukemiaA phase 2 study of inotuzumab ozogamicin in patients with indolent B-cell non-Hodgkin lymphoma refractory to rituximab alone, rituximab and chemotherapy, or radioimmunotherapy.Modern immunotherapy of adult B-lineage acute lymphoblastic leukemia with monoclonal antibodies and chimeric antigen receptor modified T cells.New insights into the pathophysiology and therapy of adult acute lymphoblastic leukemia.Treatment of adult acute lymphoblastic leukemia with inotuzumab ozogamicin.Role of inotuzumab ozogamicin in the treatment of relapsed/refractory acute lymphoblastic leukemiaImmunotherapy approaches to treat adult acute lymphoblastic leukemia.Inotuzumab ozogamicin in relapsed B-cell acute lymphoblastic leukemia.Differential impact of minimal residual disease negativity according to the salvage status in patients with relapsed/refractory B-cell acute lymphoblastic leukemia.Immunophenotypic markers in adult acute lymphoblastic leukemia: the prognostic significance of CD20 and TdT expressionInotuzumab ozogamicin in the treatment of acute lymphoblastic leukemia.
P2860

Prognostic factors for outcome in patients with refractory and relapsed acute lymphocytic leukemia treated with inotuzumab ozogamicin, a CD22 monoclonal antibody.

Item
http://www.wikidata.org/entity/Q33893777
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Prognostic factors for outcome ...... n, a CD22 monoclonal antibody.
@ast
Prognostic factors for outcome ...... n, a CD22 monoclonal antibody.
@en
type
label
Prognostic factors for outcome ...... n, a CD22 monoclonal antibody.
@ast
Prognostic factors for outcome ...... n, a CD22 monoclonal antibody.
@en
prefLabel
Prognostic factors for outcome ...... n, a CD22 monoclonal antibody.
@ast
Prognostic factors for outcome ...... n, a CD22 monoclonal antibody.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Prognostic factors for outcome ...... n, a CD22 monoclonal antibody.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932